Concomitant and productive genital infections by HSV-2 and HPV in two young women: A case report
Ilkay Başak Uysal,
Vanina Boué,
Carmen Lia Murall,
Christelle Graf,
Christian Selinger,
Christophe Hirtz,
Claire Bernat,
Jacques Ravel,
Jacques Reynes,
Marine Bonneau,
Massilva Rahmoun,
Michel Segondy,
Nathalie Boulle,
Sophie Grasset,
Soraya Groc,
Tim Waterboer,
Vincent Tribout,
Ignacio G. Bravo,
Sonia Burrel,
Vincent Foulongne,
Samuel Alizon,
Nicolas Tessandier
Affiliations
Ilkay Başak Uysal
Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France
Vanina Boué
Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France
Carmen Lia Murall
Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France
Christelle Graf
Department of Obstetrics and Gynaecology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
Christian Selinger
Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France
Christophe Hirtz
LBPC/PPC, IRMB, CHU de Montpellier and Université de Montpellier, Montpellier, France
Claire Bernat
Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France
Jacques Ravel
Institute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA
Jacques Reynes
Infectious Diseases Department, University Hospital Montpellier, Unité Mixte International, Montpellier, France; INSERM U1175/Institut de Recherche et de Developement, Unité Mixte International, Montpellier, France
Marine Bonneau
Department of Obstetrics and Gynaecology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
Massilva Rahmoun
Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France
Michel Segondy
Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, CHU Montpellier, Montpellier, France
Nathalie Boulle
Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, CHU Montpellier, Montpellier, France; Departement of Pathology and Oncobiology, Laboratory of Solid Tumors, CHU Montpellier, Montpellier, France
Sophie Grasset
Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France
Soraya Groc
Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France
Tim Waterboer
Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany
Vincent Tribout
Center for Free Information, Screening and Diagnosis (CeGIDD), Centre Hospitalier Universitaire de Montpellier, Montpellier, France
Ignacio G. Bravo
Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France
Sonia Burrel
Sorbonne Université, INSERM U1136, Institut Pierre Louis d′Epidémiologie et de Santé Publique (IPLESP), France
Vincent Foulongne
Pathogenesis and Control of Chronic Infections, Montpellier University, INSERM, EFS, Montpellier, France
Samuel Alizon
Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France; Corresponding authors at: Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France.
Nicolas Tessandier
Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France; Corresponding authors at: Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France.
Human papillomaviruses (HPVs), the most oncogenic virus known to humans, are often associated with Herpes Simplex Virus-2 (HSV-2) infections. The involvement of the latter in cervical cancer is controversial but its long-term infections might modulate the mucosal microenvironment in a way that favors carcinogenesis. We know little about coinfections between HSV-2 and HPVs, and studying the immunological and microbiological dynamics in the early stages of these infections may help identify or rule out potential interactions. We report two cases of concomitant productive, although asymptomatic, HSV-2 and HPV infections in young women (aged 20 and 25). The women were followed up for approximately a year, with clinical visits every two months and weekly self-samples. We performed quantitative analyses of their HSV-2 and HPV viral loads, immunological responses (IgG and IgM antibodies and local cytokines expression profiles), vaginal microbiota composition, as well as demographic and behavior data. We detect interactions between virus loads, immune response, and the vaginal microbiota, which improve our understanding of HSV-2 and HPVs’ coinfections and calls for further investigation with larger cohorts.